Troponin-C2 Human

Troponin-C2 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Functional Role in Muscle Contraction

TnC2 mediates Ca²⁺-dependent activation of cardiac muscle contraction through a multi-step mechanism:

  1. Ca²⁺ binding: Ca²⁺ ions bind to the second EF-hand of TnC2, inducing conformational changes .

  2. Structural reorganization: The N-terminal domain of TnC2 interacts with TnI, displacing TnI from actin and tropomyosin (Tm) .

  3. Tropomyosin shift: Reduced TnI-Tm inhibition allows Tm to shift along actin, exposing myosin-binding sites .

  4. Cross-bridge formation: Myosin heads bind actin, triggering ATP hydrolysis and muscle contraction .

Diagnostic Utility

Elevated cardiac troponin levels (TnI or TnT) are diagnostic biomarkers for myocardial injury, including acute myocardial infarction (AMI) and myocardial infarction type 2 . High-sensitivity assays detect troponin at concentrations as low as 1–10 ng/L, enabling early diagnosis .

Troponin LevelRisk CategoryPrimary Outcome Incidence (per 100 patient-years)
<5 ng/L (low)Low risk1.58
5–99th percentileIntermediate risk4.64
>99th percentileHigh risk6.13

Prognostic Implications

In chronic coronary artery disease, even mildly elevated troponin levels predict adverse outcomes:

  • Troponin <2 ng/L: 2.8% risk of myocardial infarction or cardiovascular death .

  • Troponin >99th percentile: 13.4% risk .

  • Stable high-sensitivity cardiac troponin T (hs-cTnT): Linked to increased heart failure hospitalization and mortality .

Genetic and Pathological Links

  • Cardiomyopathies: Mutations in TnC2-associated genes (e.g., TNNC1) are implicated in familial hypertrophic cardiomyopathy .

  • COVID-19: Elevated troponin levels correlate with myocardial injury and poor prognosis in SARS-CoV-2 infection .

Therapeutic Targets

  • Direct modulation: Small molecules targeting TnC2’s Ca²⁺-binding domain may enhance contractility in heart failure .

  • Biomarker-guided therapy: Prognostic troponin thresholds inform revascularization strategies in chronic coronary disease .

Comparative Data: Troponin Subunits

SubunitRoleClinical BiomarkerPathological Associations
TnC2Ca²⁺ bindingNo (TnI/TnT preferred)Hypertrophic cardiomyopathy
TnIActin inhibitionYes (cTnI assays)Myocardial infarction, dilated cardiomyopathy
TnTTropomyosin anchoringYes (cTnT assays)Acute coronary syndrome, heart failure

Product Specs

Introduction
Troponin-C2 (Troponin C, skeletal muscle) is the central regulatory protein of striated muscle contraction and modulates the calcium ion activation properties of muscle fibers. Troponin-C2 is a complex of three subunits, Troponin I (Tn-I), Troponin T (Tn-T), and Troponin C (Tn-C). The Tn-I subunit inhibits actomyosin ATPase. The Tn-T subunit binds tropomyosin and Tn-C. The Tn-C subunit binds calcium and overcomes the inhibitory action of the troponin complex on actin filaments. Mutations in the genes encoding any of these subunits have been linked with skeletal muscle disease.
Description
Recombinant human Troponin-C2 produced in E. coli is a single, non-glycosylated polypeptide chain of 160 amino acids with a molecular mass of 18.1 kDa. The recombinant human Troponin-C2 protein is purified by proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The protein (1 mg/mL) is supplied in 20 mM Tris-HCl buffer (pH 7.5), 1 mM DTT, 100 mM NaCl, and 10% glycerol.
Stability
For short-term storage, store at 4°C for up to 4 weeks. For long-term storage, store at -20°C. It is recommended to add a carrier protein (0.1% HSA or BSA) for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Synonyms

Troponin C, skeletal muscle, TNNC2.

Source
Escherichia Coli.
Amino Acid Sequence

MTDQQAEARS YLSEEMIAEF KAAFDMFDAD GGGDISVKEL GTVMRMLGQT PTKEELDAII EEVDEDGSGT IDFEEFLVMM VRQMKEDAKG KSEEELAECF RIFDRNADGY IDPEELAEIF RASGEHVTDE EIESLMKDGD KNNDGRIDFD EFLKMMEGVQ.

Q&A

What is the fundamental role of Troponin-C2 in muscle physiology?

Troponin-C2, fast skeletal type (TNNC2) functions as a critical component in the troponin complex located on the thin filament of striated muscles. Its primary role involves calcium binding during muscle contraction, triggering conformational changes in the troponin-tropomyosin complex that enable actin-myosin interactions. Research indicates that TNNC2 participates extensively in the calcium signaling pathway, serving as a calcium sensor that regulates muscle contraction in response to alterations in intracellular calcium ion concentration . Unlike cardiac troponin variants, TNNC2 demonstrates tissue specificity to fast-twitch skeletal muscle fibers, contributing to their distinctive contractile properties.

How does TNNC2 expression vary between different tissue types?

TNNC2 shows highly selective expression patterns, predominantly in fast skeletal muscle tissue. While various troponin isoforms exhibit developmental regulation and tissue-specific expression through alternative splicing mechanisms , TNNC2 maintains relatively consistent expression in fast-twitch muscle fibers. Research approaches to studying this expression pattern typically employ microarray gene expression analysis or RNA-sequencing techniques with careful experimental design to account for tissue variability. When designing experiments to examine TNNC2 expression across tissues, researchers should consider implementing a reference design where each sample is paired to the same reference material, which facilitates more reliable cross-tissue comparisons .

What structural features of TNNC2 enable its calcium-binding function?

TNNC2 contains specialized EF-hand motifs that form the calcium-binding domains of the protein. These helix-loop-helix structural elements undergo conformational changes upon calcium binding, initiating the cascade that leads to muscle contraction. The protein's unique structural features enable its participation in the calcium signaling pathway, distinguishing it from other calcium-binding proteins . When studying these structural elements, researchers should consider both the conserved regions that maintain basic calcium-binding functions and the variable regions that may contribute to tissue-specific properties of TNNC2.

What experimental design considerations are critical when studying sex-associated differences in TNNC2 expression?

When investigating sex-associated differences in TNNC2 expression, researchers should implement a carefully controlled experimental design that accounts for multiple variables. Studies have identified significant differences in TNNC2 expression patterns between males and females, particularly in conditions like ankylosing spondylitis (AS) . A robust experimental approach requires:

  • Balanced sample selection with sufficient biological replicates (minimum n=3 per sex)

  • Matched controls accounting for age, comorbidities, and medication use

  • Consideration of hormonal status and cycle in female subjects

  • Implementation of dye-swap experiments in microarray studies to control for technical bias

  • Statistical analysis methods that can detect subtle sex-based differences

The experimental design should also account for potential confounding factors through either randomization or restriction of inclusion criteria . For microarray studies specifically, a loop design where each sample is compared to samples from other groups may provide more statistical power than simple pairwise comparisons .

How can researchers effectively analyze contradictory data in TNNC2 functional studies?

When encountering contradictory results in TNNC2 functional studies, researchers should apply a systematic approach:

  • Assess methodological differences between studies, including experimental models, calcium concentration measurements, and protein interaction detection methods

  • Evaluate sample heterogeneity, particularly regarding sex differences which have been shown to influence TNNC2 expression and function

  • Analyze potential splice variants or post-translational modifications that might affect function

  • Consider gene-environment interactions that could modify TNNC2 activity

  • Implement statistical approaches that can detect heterogeneous effects within subject populations

The heteroplasmy analysis approaches used in mitochondrial genetics studies provide a useful framework for analyzing contradictory data, particularly when assessing the impact of variable expression levels . Researchers should consider modeling approaches that incorporate selection coefficients to explain observed variations, similar to those used in iPSC studies .

What are the recommended approaches for studying TNNC2's role in protein-protein interaction networks?

To effectively study TNNC2's role in protein-protein interaction networks, researchers should:

  • Employ a combination of computational and experimental approaches

  • Begin with database-driven PPI network construction using tools like STRING and visualization with Cytoscape

  • Identify hub genes through algorithms like CytoHubba to determine TNNC2's centrality in the network

  • Validate predicted interactions using co-immunoprecipitation or proximity ligation assays

  • Perform functional validation through gene knockdown/knockout experiments

  • Integrate PPI data with pathway analysis, particularly focusing on calcium signaling pathways

Research has identified TNNC2, through such network analyses, as one of the key hub genes involved in muscle function and calcium signaling, with potential implications for conditions showing sex-based differences like ankylosing spondylitis .

How does TNNC2 contribute to the pathogenesis of ankylosing spondylitis, and what sex-specific patterns have been observed?

TNNC2 has been identified as a key molecule contributing to sex-associated differences in ankylosing spondylitis (AS) . Research indicates:

  • Differential expression of TNNC2 between male and female AS patients

  • Involvement in calcium signaling pathways that may influence disease progression

  • Function as a hub gene in protein-protein interaction networks relevant to AS

The mechanistic contribution appears to involve TNNC2's role in calcium homeostasis and signaling, which may influence inflammatory processes and tissue remodeling differently in males versus females. The sex-specific patterns suggest that estrogen or testosterone might modulate TNNC2 expression or function, potentially explaining why AS presents differently between sexes . This understanding points to TNNC2 as a potential target for developing sex-specific therapeutic approaches for AS.

What methodological approaches are recommended for investigating TNNC2 as a therapeutic target?

When investigating TNNC2 as a therapeutic target, researchers should implement a systematic approach:

  • Target validation studies:

    • Confirm differential expression in disease states using qPCR and western blot

    • Perform functional studies in relevant cell culture models

    • Utilize animal models that recapitulate disease-specific TNNC2 dysregulation

  • High-throughput screening approaches:

    • Develop calcium-binding assays specific to TNNC2

    • Screen compound libraries for molecules that modulate TNNC2 activity

    • Implement cell-based assays that measure downstream effects of TNNC2 modulation

  • Lead optimization strategies:

    • Focus on compounds that specifically target TNNC2 without affecting cardiac troponin variants

    • Assess sex-specific effects of candidate compounds

    • Evaluate effects on calcium signaling pathways in relevant tissues

  • Translational considerations:

    • Develop biomarkers based on TNNC2 activity for patient stratification

    • Design clinical trials that account for sex-based differences in TNNC2 function

This methodological framework builds upon research identifying TNNC2 as a potential molecular target for personalized treatment of conditions like ankylosing spondylitis .

What are the optimal sample preparation protocols for studying TNNC2 in human tissue samples?

When preparing human tissue samples for TNNC2 analysis, researchers should consider:

  • Tissue collection:

    • Rapid freezing in liquid nitrogen to preserve protein integrity

    • Careful documentation of donor sex, age, and disease status

    • Collection of both affected and unaffected tissues when possible

  • Protein extraction:

    • Use of specialized buffers containing calcium chelators to preserve native conformation

    • Gentle homogenization techniques to maintain protein-protein interactions

    • Subcellular fractionation to isolate myofibrillar components

  • Quality control:

    • Assessment of sample integrity through gel electrophoresis

    • Verification of TNNC2 antibody specificity using both positive and negative controls

    • Implementation of pooling strategies only when necessary, with careful consideration of potential pitfalls

  • Storage considerations:

    • Aliquoting samples to avoid freeze-thaw cycles

    • Documentation of storage conditions for reproducible research

These protocols should be optimized based on the specific analytical technique planned, whether for protein quantification, interaction studies, or functional assays.

What emerging technologies hold promise for advancing TNNC2 research?

Several cutting-edge technologies show particular promise for TNNC2 research:

  • Single-cell transcriptomics:

    • Enables analysis of TNNC2 expression heterogeneity within tissues

    • Allows for identification of cell subpopulations with differential expression

    • Facilitates understanding of cell-specific regulatory mechanisms

  • CRISPR-based functional genomics:

    • Permits precise editing of TNNC2 gene to study function

    • Enables creation of isogenic cell lines with specific variants

    • Facilitates high-throughput screening of regulatory elements

  • Structural biology approaches:

    • Cryo-EM studies of the troponin complex under different calcium concentrations

    • Advanced NMR techniques to study TNNC2's dynamic calcium binding properties

    • Molecular dynamics simulations to predict functional consequences of variants

  • Integrative multi-omics:

    • Combined analysis of genomics, transcriptomics, proteomics, and metabolomics data

    • Systems biology approaches to model TNNC2's role in calcium signaling networks

    • Machine learning algorithms to identify complex patterns in TNNC2 regulation

  • Patient-derived models:

    • iPSC-derived muscle cells from patients with relevant conditions

    • Organoid models to study TNNC2 in tissue-like environments

    • Humanized animal models for in vivo studies

These technologies could particularly advance understanding of sex-specific differences in TNNC2 function and its role in disease pathogenesis .

What are the critical unresolved questions regarding TNNC2's role in human physiology and pathology?

Despite progress in TNNC2 research, several critical questions remain unresolved:

  • Regulatory mechanisms:

    • How is TNNC2 expression regulated in different physiological and pathological states?

    • What transcription factors and epigenetic mechanisms control its tissue-specific expression?

    • How do sex hormones influence TNNC2 expression and function?

  • Functional heterogeneity:

    • Do different splice variants of TNNC2 have distinct functional properties?

    • How do post-translational modifications affect TNNC2's calcium binding properties?

    • What is the functional significance of TNNC2 variants identified in human populations?

  • Disease mechanisms:

    • How exactly does TNNC2 contribute to sex-associated differences in ankylosing spondylitis?

    • Are there other musculoskeletal or inflammatory conditions where TNNC2 plays a role?

    • Can TNNC2 function as a biomarker for disease progression or treatment response?

  • Therapeutic potential:

    • Can TNNC2 be targeted pharmacologically without affecting cardiac troponin function?

    • Would sex-specific modulation of TNNC2 provide therapeutic benefits in certain conditions?

    • What are the long-term consequences of modulating TNNC2 activity?

Addressing these questions will require interdisciplinary approaches combining molecular biology, structural biology, systems biology, and clinical research to fully elucidate TNNC2's role in human health and disease.

Product Science Overview

Structure and Function

Troponin-C2 is part of the troponin complex, which consists of three subunits:

  • Troponin I (Tn-I): Inhibits actomyosin ATPase.
  • Troponin T (Tn-T): Binds tropomyosin and Troponin C.
  • Troponin C (Tn-C): Binds calcium ions and overcomes the inhibitory action of the troponin complex on actin filaments .

The binding of calcium to Troponin-C2 induces a conformational change that allows the interaction between actin and myosin, leading to muscle contraction. This process is essential for the proper functioning of skeletal muscles .

Recombinant Human Troponin-C2

Recombinant human Troponin-C2 is produced using Escherichia coli (E. coli) as the expression system. The recombinant protein corresponds to the amino acids 1-160 of the human TNNC2 gene . It is purified using conventional chromatography techniques to achieve a purity of over 95% .

The recombinant protein is typically stored in a buffer containing Tris-HCl, DTT, NaCl, and glycerol to maintain its stability and activity .

Applications and Research

Recombinant human Troponin-C2 is widely used in research to study muscle physiology, muscle diseases, and the mechanisms of muscle contraction. It is also used in the development of diagnostic assays and therapeutic interventions for muscle-related disorders .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.